VIGEO THERAPEUTICS
Vigeo Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutic agents intended to treat an advanced malignant tumor that can effectively treat multiple types of cancer and improve the lives of patients. The company building a first-in-class drug discovery pipeline that reprograms the tumor immune microenvironment (TIME). They plan to commence multiple combination studies to evaluate VT1021 in combination with chemotherapies and/or anti-PD-1 antibodies. The company was established in 2011 and is headquartered in Cambridge, Massachusetts.
VIGEO THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vigeotherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
617-945-0385
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
Euro SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS GoDaddy
Similar Organizations
Aegerion Pharmaceuticals
Aegerion Pharmaceuticals engages in the development of therapeutics and pharmaceuticals to treat cardiovascular and metabolic diseases.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Biodel
Biodel is a biopharmaceutical company developing and commercializing therapeutics for the treatment of diabetes.
Cascadian Therapeutics
Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
Cornerstone Therapeutics
Cornerstone Therapeutics is a pharmaceutical company focused on developing and commercializing products for the respiratory system.
Microbion
Microbion is a pharmaceutical company developing therapeutics for the treatment of bacterial infections.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Progenics Pharmaceuticals
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Morningside Venture Investments
Morningside Venture Investments investment in Series A - Vigeo Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-21 | Vigeo Therapeutics Provides Clinical Update for Lead Asset VT1021 and Welcomes New Chief Executive Officer |
Official Site Inspections
http://www.vigeotherapeutics.com Semrush global rank: 13.19 M Semrush visits lastest month: 78
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vigeo Therapeutics"
Overview - Vigeo
To provide financing for the development of its science and its organization, Vigeo has partnered with Morningside Venture Investments, Ltd, a private equity and venture capital firm founded in …See details»
Vigeo Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 617-945-0385 Vigeo Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutic agents intended to …See details»
Vigeo Therapeutics - PitchBook
Vigeo Therapeutics General Information Description. Developer of novel therapeutic agents designed to treat advanced malignant tumors. The company's anti-cancer agent is a peptide …See details»
Vigeo Therapeutics - LinkedIn
Vigeo Therapeutics | 865 followers on LinkedIn. It’s TIME to beat cancer. | Vigeo Therapeutics is a clinical stage company developing novel therapeutic agents for the treatment of cancer.See details»
Vigeo Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Jul 9, 2023 www.vigeotherapeutics.com. Holding Company | 2011 | Massachusetts, United States | 10-50 | www.vigeotherapeutics.com. Last update 08 May 2025. Overview. Pipeline. …See details»
Vigeo Therapeutics - Overview, News & Similar companies
Jun 2, 2023 Vigeo Therapeutics contact info: Phone number: (617) 340-6073 Website: www.vigeotherapeutics.com What does Vigeo Therapeutics do? Based in Cambridge, MA, …See details»
Vigeo Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Vigeo Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Working At Vigeo Therapeutics: Company Overview and Culture
Vigeotherapeutics.com. Organization Type. Private. Social Media. Vigeo Therapeutics, Inc. operates in the healthcare industry focusing on biotechnology business. Based in Cambridge, …See details»
Vigeo Therapeutics Overview | SignalHire Company Profile
Phone Number: 1-617-945-0385: Vigeo Therapeutics industries Biotech: Headquarters Location: 545 Concord Ave, Cambridge, Massachusetts, 02138 US 545 Concord Ave, Cambridge,...See details»
Vigeo Therapeutics Company Profile | Management and
[email protected]: Vigeo Therapeutics Top Competitors. Company Employees Revenue Top technologies; Admunex Therapeutics Inc. 6: $1.3 M: Melior Discovery Inc. 32: …See details»
Pipeline - Vigeo
Our clinical program. Vigeo Therapeutics is an immunotherapy company focused on developing therapies to fight cancer and inflammation. Vigeo is a leader in understanding the important …See details»
Vigeo Therapeutics Company Overview, Contact Details
Mar 25, 2021 [email protected]: [email protected]: 96%. [email protected]: [email protected]: 4%. See more formats. …See details»
Vigeo Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Vigeo Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Vigeo Therapeutics Revenue, Growth & Competitor Profile
Apr 7, 2025 Vigeo Therapeutics's Annual Report & Profile shows critical firmographic facts: What is the company's size? (Annual sales and employees) Vigeo Therapeutics's annual revenues …See details»
Vigeo Therapeutics Advances VT1021 Into Phase 2-3 …
Jan 20, 2022 For more information visit vigeotherapeutics.com or follow us on LinkedIn and Twitter. About Global Coalition for Adaptive Research (GCAR) ... (GCAR) is a 501(c)(3) …See details»
Vigeo Therapeutics Advances VT1021 Into Phase 2-3 …
Jan 20, 2022 For more information visit vigeotherapeutics.com or follow us on LinkedIn and Twitter. ... (GCAR) is a 501(c)(3) nonprofit organization uniting physicians, clinical researchers, …See details»
Overview - Vigeo
Oct 1, 2023 ONCOLOGY & INFLAMMATION . Oncology 4 ways to defeat cancer. Vigeo is focusing on tumors that are largely refractory to approved therapies. Our approach to drug …See details»
Our Team - Vigeo
Michael J. Cieslewicz, PhD Vice President, Project Management and Operations. Bill Craig, PhD Head of CMC. Victor Zota, MD Director, Pathology LabSee details»
Vigeo Therapeutics Provides Clinical Update for Lead Asset …
Sep 21, 2021 Phase 1/2 Dose Expansion Studies in Recurrent Glioblastoma and Pancreatic Cancer Completed; Results to be Reported at Key Medical Meetings During Q4 2021 …See details»
OGSIVEO (nirogacestat) FDA Approved for Desmoid Tumors
CARY, N.C., Dec. 5, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by SpringWorks Therapeutics as a …See details»